Maria Teresa is a neuroimmunologist and science advocate with over 10-year international experience in the field of Alzheimer’s disease, and a unique expertise on sex and gender differences. After a master in Pharmaceutical Chemistry in 2005 (University of Cagliari, Italy) and a stage at the Center of Excellence for Drug Discovery of GlaxoSmith&Kline (Harlow, England), she obtained a PhD in Pharmacology and Therapeutics at McGill University (Montreal, Canada) in 2011 with a thesis on the role of inflammation in Alzheimer’s Disease. In 2011 she moved back to Europe and joined the Nitsch’s lab (University of Zurich, Switzerland) as postdoc and group leader, to identify novel biomarkers for increasing individual level prediction of cognitive decline and Alzheimer’s. In 2016 Maria Teresa co-founded the non-profit organization called ‘Women’s Brain Project’ (WBP, CHE-369.271.906), focusing on sex- and gender-sensitive precision medicine for brain and mental diseases such as Alzheimer, migraine, multiple sclerosis, depression etc (www.womensbrainproject.com). Her work as WBP Chief Scientific Officer has led to several scientific publications in leading journals including Nature, Science and PNAS, three TED-x talks (https://youtu.be/9nWpkv0o55U), and coverage by both the national (Sonntagszeitung, SwissInfo, NZZ, Le Temps) and the international press (including BBC, The Independent, Sciences et Avenir, Financial Times, La Stampa, ELLE Italy). She is currently Faculty member of the course in advanced studies for sex and gender differences offered by University of Zurich, and POL instructor at the Medical University of Vienna.